Table 10: Commercially available POC devices for genetic disorders detection.

POC NAME MEASURED PARAMETERS TEST TIME IMPRECISION ACCURACY
Carestart™ (Access Bio, Somerset, USA) [344-346] G-6-PDH activity 10 minutes N/A r = 0.73
G6PD Assay (Trinity Biotech, St. Louis, USA) [344, 347] G-6-PDH activity < 70 minutes CV = 4.5% r = 0.98
Sickle SCAN™ test (BioMedomics, Inc., Durham, USA) [348-351] HbA, HbS, HbC 2 minutes N/A r = 0.99
Q3 portable real-time PCR instrument (Thermo Fisher Scientific, Waltham, USA) [352] ABCB1 3435, CYP2C19*2
and CYPC2C19*17 polymorphisms
30 minutes N/A r = 1.00
GeneXpert® (Cepheid, Sunnyvale, USA) [353] BCR-ABL gene fusion in leukemia cells 150 minutes CV = 41.35% r = 0.99
Verigene CYP2C19 Nucleic Acid Test (Nanosphere Inc, Northbrook, USA) [354, 355] CYP2C19 polymorphisms 210 minutes N/A r = 1.00
RX CYP2C19 System (Spartan Bioscience Inc., Ottawa, Canada) [355, 356] CYP2C19 polymorphisms < 60 minutes N/A r = 1.00

(G-6-PDH = Glucose 6-Phosphate Dehydrogenase; HbA = adult normal hemoglobin; HbS = human sickle cell hemoglobin; HbC = human hemoglobin C; CYP2C19 = Cytochrome P450 2C19).